300573SZSE

Announcement on Completion of Share Repurchase Cancellation and Share Change

✨ AI Summary

Shenyang Xingqi Pharmaceutical Co., Ltd. announces the completion of its share repurchase cancellation. 2,405,040 shares were cancelled, reducing the total share capital by 0.67%. The cancellation is effective from August 7, 2026, and does not materially impact the company's operations or listing status.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 300573

Stock Abbreviation: Xingqi Pharmaceutical

Announcement Number: 2026-044

Shenyang Xingqi Pharmaceutical Co., Ltd.

Announcement on Completion of Share Repurchase Cancellation and Share Change

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or major omissions.

Special Notice:

  1. Shenyang Xingqi Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has cancelled 2,405,040 repurchased shares, accounting for 0.67% of the Company's total share capital before cancellation. The amount involved in the repurchase and cancellation is RMB 99,979,981.43. After this cancellation, the Company's total share capital has decreased from 357,322,814 shares to 354,917,774 shares.

  2. After review and confirmation by the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited, the cancellation of the repurchased shares by the Company became effective on August 7, 2026.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.